These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 27587544)
21. How Do the New Definitions for Multidrug-Resistant Tuberculosis Treatment Outcomes Really Perform? Gebhard A; van den Hof S; Cobelens F Am J Respir Crit Care Med; 2015 Jul; 192(1):117. PubMed ID: 26131997 [No Abstract] [Full Text] [Related]
22. Reply: How Do the New Definitions for Multidrug-Resistant Tuberculosis Treatment Outcomes Really Perform? Bastard M; Bonnet M; du Cros P; Khamraev AK; Hayrapetyan A; Kimenye K; Khurkhumal S; Dlamini T; Telnov A; Sanchez-Padilla E; Hewison C; Varaine F Am J Respir Crit Care Med; 2015 Jul; 192(1):117-8. PubMed ID: 26131996 [No Abstract] [Full Text] [Related]
23. Eligibility for shorter treatment of multidrug-resistant tuberculosis in the European Union. van der Werf MJ; Hollo V; Ködmön C; Dara M; Catchpole M Eur Respir J; 2017 Mar; 49(3):. PubMed ID: 28331041 [TBL] [Abstract][Full Text] [Related]
24. Multi-drug resistant Mycobacterium tuberculosis & oxidative stress complexity: Emerging need for novel drug delivery approaches. Dua K; Rapalli VK; Shukla SD; Singhvi G; Shastri MD; Chellappan DK; Satija S; Mehta M; Gulati M; Pinto TJA; Gupta G; Hansbro PM Biomed Pharmacother; 2018 Nov; 107():1218-1229. PubMed ID: 30257336 [TBL] [Abstract][Full Text] [Related]
32. Challenges and Outlooks in Multi-drug Resistant Tuberculosis. Caminero Luna JA Arch Bronconeumol; 2017 Aug; 53(8):417-418. PubMed ID: 28314633 [No Abstract] [Full Text] [Related]
33. [Attributable factors to the emergence of multidrug-resistant Mycobacterium tuberculosis based on the observation of consecutive drug resistance test results]. Fujino T; Hasegawa N; Satou R; Komatsu H; Kawada K Kekkaku; 1998 Jul; 73(7):471-6. PubMed ID: 9739579 [TBL] [Abstract][Full Text] [Related]
34. Resistant plus susceptible tuberculosis: the undiscovered country. Ahmad Khan F; Behr M J Infect Dis; 2014 Jun; 209(11):1682-4. PubMed ID: 24523512 [No Abstract] [Full Text] [Related]
35. [Increasing transmission of tuberculosis in the world. Multiresistant strains are the greatest threat]. Tärnvik A Lakartidningen; 2000 Nov; 97(48):5590-2. PubMed ID: 11187373 [No Abstract] [Full Text] [Related]
36. Drug-resistant tuberculosis: reality and potential threat. Lalloo UG Int J Tuberc Lung Dis; 2010 Mar; 14(3):255-8. PubMed ID: 20132610 [No Abstract] [Full Text] [Related]
37. Safety and tolerability of clarithromycin in the treatment of multidrug-resistant tuberculosis. Van der Paardt AL; Akkerman OW; Gualano G; Palmieri F; Davies Forsman L; Aleksa A; Tiberi S; de Lange WC; Bolhuis MS; Skrahina A; van Soolingen D; Kosterink JG; Migliori GB; van der Werf TS; Alffenaar JC Eur Respir J; 2017 Mar; 49(3):. PubMed ID: 28331034 [No Abstract] [Full Text] [Related]
38. Fluoroquinolones in multidrug-resistant tuberculosis. Mohapatra PR Am J Respir Crit Care Med; 2004 Oct; 170(8):920-1. PubMed ID: 15475406 [No Abstract] [Full Text] [Related]